Examination of the medical treatment by the pancrelipase to the refractory inflammatory bowel disease patient
Not Applicable
- Conditions
- Crohn's disease Ulcerative colitis
- Registration Number
- JPRN-UMIN000014205
- Lead Sponsor
- Department of Gastroenterology Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patient who has merged chronic pancreatitis 2) A patient with the past of the stomach and pancreatectomy 3) The patient who has allergy in pig protein 4) A patient under a pregnant woman and breast-feeding and with a possibility of having become pregnant 5) The patient who has participated in other clinical trials 6) The patient who has suffered from critical infection. 7) The patient who was not able to get consent to the participation in this clinical study. In addition, the patient whom the examination responsibility (assignment) doctor judged to be unsuitable as a subject.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Does the increase group in BMI 5% after 24 weeks of medication exceed a threshold value effectiveness rate from before medication or not?
- Secondary Outcome Measures
Name Time Method